{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:54:12Z","timestamp":1792760052058,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","award":["HURF-2017-38"],"award-info":[{"award-number":["HURF-2017-38"]}],"id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015515","name":"Kementerian Pendidikan Malaysia","doi-asserted-by":"publisher","award":["NRF-2016R1D1A1B03935447"],"award-info":[{"award-number":["NRF-2016R1D1A1B03935447"]}],"id":[{"id":"10.13039\/501100015515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.humpath.2018.03.025","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T13:50:34Z","timestamp":1523109034000},"page":"28-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition"],"prefix":"10.1016","volume":"80","author":[{"given":"Mi Jung","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Soo","family":"Rho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sook","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Rim","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kee","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumjung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyueng-Whan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.03.025_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOO.0b013e32832984c0","article-title":"Oropharyngeal cancer: current understanding and management","volume":"17","author":"Cohan","year":"2009","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.humpath.2018.03.025_bb0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/01.mlg.0000217543.40027.1d","article-title":"Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck","volume":"116","author":"Lim","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.humpath.2018.03.025_bb0015","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archoto.2009.164","article-title":"A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma","volume":"135","author":"Jaber","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.humpath.2018.03.025_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/1414-431X20132703","article-title":"Impact of HPV infection on the development of head and neck cancer","volume":"46","author":"Betiol","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.humpath.2018.03.025_bb0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.humpath.2014.03.003","article-title":"Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus\u2013negative tonsillar squamous cell carcinoma and their prognostic significances","volume":"45","author":"Kwon","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0030","doi-asserted-by":"crossref","first-page":"82399","DOI":"10.18632\/oncotarget.19390","article-title":"Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection","volume":"8","author":"Kwon","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.025_bb0035","doi-asserted-by":"crossref","first-page":"8389","DOI":"10.3748\/wjg.v22.i37.8389","article-title":"Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma","volume":"22","author":"Kim","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0040","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-015-4903-7","article-title":"Clinicopathologic analysis of PD-L1 and PD-L2 expression in renal cell carcinoma: association with oncogenic proteins status","volume":"23","author":"Shin","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0045","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/annonc\/mdu438.32","article-title":"A phase IB study of pembrolizumab (PEMBRO;MK-3475) in patients (pts) with human papillomavirus (HPV)\u2013positive and negative head and neck cancer (HNC)","volume":"25","author":"Chow","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0050","doi-asserted-by":"crossref","first-page":"77010","DOI":"10.18632\/oncotarget.12776","article-title":"PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.025_bb0055","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.03.025_bb0060","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.18632\/oncotarget.7431","article-title":"PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma","volume":"7","author":"Ock","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.025_bb0065","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":"Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2018.03.025_bb0070","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1074\/jbc.M114.612689","article-title":"Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression","volume":"290","author":"Balan","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2018.03.025_bb0075","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.humpath.2013.03.004","article-title":"TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma","volume":"44","author":"Kwon","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0080","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/gcc.20755","article-title":"TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer","volume":"49","author":"Okada","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2018.03.025_bb0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pathol.2016.07.003","article-title":"Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype","volume":"48","author":"Satgunaseelan","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2018.03.025_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186192","article-title":"Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer","volume":"12","author":"Nakamura","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.03.025_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jclinpath-2017-204525","article-title":"PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry","volume":"71","author":"El Jabbour","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.03.025_bb0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4143\/crt.2015.249","article-title":"Association between PD-L1 and HPV status and the prognostic value of PD-L1 in oropharyngeal squamous cell carcinoma","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.humpath.2018.03.025_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1056427","article-title":"HIPK2 overexpression and its prognostic role in human papillomavirus\u2013positive tonsillar squamous cell carcinoma","volume":"2017","author":"Kwon","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.humpath.2018.03.025_bb0115","series-title":"World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon","first-page":"166","article-title":"Tumours of the oral cavity and oropharynx","author":"Slootweg","year":"2005"},{"key":"10.1016\/j.humpath.2018.03.025_bb0120","series-title":"AJCC cancer staging manual","first-page":"41","article-title":"Pharynx","author":"Edge","year":"2010"},{"key":"10.1016\/j.humpath.2018.03.025_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4132\/KoreanJPathol.2013.47.3.203","article-title":"Histopathologic predictors of lymph node metastasis and prognosis in tonsillar squamous cell carcinoma","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.21873\/anticanres.11465","article-title":"PD-L1 expression confers better prognosis in locally advanced oral squamous cell carcinoma","volume":"37","author":"Kogashiwa","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2018.03.025_bb0135","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1158\/0008-5472.CAN-05-4303","article-title":"Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up","volume":"66","author":"Thompson","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.03.025_bb0140","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2018.03.025_bb0145","doi-asserted-by":"crossref","first-page":"20902","DOI":"10.18632\/oncotarget.3939","article-title":"Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells","volume":"6","author":"Oliveira-Costa","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.025_bb0150","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.oraloncology.2015.08.011","article-title":"Associations among pretreatment tumor necrosis and the expression of HIF-1alpha and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof","volume":"51","author":"Chen","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0155","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bjc.2014.555","article-title":"PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients","volume":"112","author":"D'Incecco","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2018.03.025_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2018.03.025_bb0170","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2015.108","article-title":"Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers","volume":"28","author":"Mezache","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2018.03.025_bb0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.03.025_bb0180","doi-asserted-by":"crossref","first-page":"42067","DOI":"10.18632\/oncotarget.5955","article-title":"PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47\/SIRPalpha axis in HPV negative head and neck squamous cell carcinoma","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:34:45Z","timestamp":1758645285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718301175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":36,"alternative-id":["S0046817718301175"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.03.025","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}